Boosted protease inhibitor + Emtricitabine/Tenofovir Disoproxil Fumarate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Boosted protease inhibitor + Emtricitabine/Tenofovir Disoproxil Fumarate, covering 2018-11-09 to 2018-11-09. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants [Phase 3]